Predictors for short bowel syndrome in Crohn's disease.

[1]  C. Buskens,et al.  284 EARLY LAPAROSCOPIC ILEOCECAL RESECTION DECREASES NEED FOR MEDICAL TREATMENT AND SURGERY IN INFLAMMATORY ILEOCECAL CROHN'S DISEASE: LONG-TERM FOLLOW UP OF THE LIR!C TRIAL , 2020 .

[2]  L. Stassen,et al.  ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment. , 2019, Journal of Crohn's & colitis.

[3]  L. Stassen,et al.  ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment. , 2019, Journal of Crohn's & colitis.

[4]  D. Seidner,et al.  Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study. , 2019, Clinical nutrition.

[5]  X. Jouven,et al.  Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study , 2018, Alimentary pharmacology & therapeutics.

[6]  M. Dubinsky,et al.  Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort , 2018, Journal of Crohn's & colitis.

[7]  V. Andersen,et al.  Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study , 2018, Gut.

[8]  A. Forbes,et al.  Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey. , 2017, Clinical nutrition.

[9]  C. Buskens,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. , 2017, Journal of Crohn's & colitis.

[10]  H. Tilg,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management , 2017, Journal of Crohn's & colitis.

[11]  J. Sanderson,et al.  Patient optimization for surgery relating to Crohn's disease , 2016, Nature Reviews Gastroenterology &Hepatology.

[12]  D. Quilliot,et al.  Définition et épidémiologie du grêle court et de l’insuffisance intestinale , 2016 .

[13]  F. Rochling,et al.  Initial Site of Crohn’s Disease is not an Independent Predictor of Outcome of Short Bowel Syndrome , 2016 .

[14]  E. Lyden,et al.  Initial Site of CrohnâÂÂs Disease is not an Independent Predictor of Outcome of Short Bowel Syndrome , 2016 .

[15]  S. Hanauer,et al.  Treat to target: a proposed new paradigm for the management of Crohn's disease. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  A. Forbes,et al.  ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. , 2015, Clinical nutrition.

[17]  D. Fan,et al.  A network meta-analysis on the efficacy of 5-aminosalicylates, immunomodulators and biologics for the prevention of postoperative recurrence in Crohn's disease. , 2014, International journal of surgery.

[18]  H. Ikeuchi,et al.  Long-term incidence and characteristics of intestinal failure in Crohn’s disease: a multicenter study , 2014, Journal of Gastroenterology.

[19]  A. Amiot,et al.  Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. , 2013, Clinical nutrition.

[20]  P. Lakatos,et al.  Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort. , 2013, World journal of gastroenterology.

[21]  L. Peyrin-Biroulet,et al.  Clinical Risk Factors for Complicated Disease: How Reliable Are They? , 2013, Digestive Diseases.

[22]  H. Ikeuchi,et al.  Risk factors for short bowel syndrome in patients with Crohn’s disease , 2012, Surgery Today.

[23]  G. Savoye,et al.  Crohn’s disease patients with chronic intestinal failure receiving long‐term parenteral nutrition: a cross‐national adult study , 2011, Alimentary pharmacology & therapeutics.

[24]  S. Hanauer,et al.  Assessing Response and Loss of Response to Biological Therapies in IBD , 2011, The American Journal of Gastroenterology.

[25]  L. Peyrin-Biroulet,et al.  The Natural History of Adult Crohn's Disease in Population-Based Cohorts , 2010, The American Journal of Gastroenterology.

[26]  S. Ng,et al.  Management of Postoperative Crohn's Disease , 2008, The American Journal of Gastroenterology.

[27]  M. Vos,et al.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial , 2008, The Lancet.

[28]  M. Vatn,et al.  Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  K. Iyer,et al.  Short bowel syndrome and crohn’s disease , 2003, Journal of Gastrointestinal Surgery.

[30]  A. Buchman,et al.  Short bowel syndrome and intestinal failure: consensus definitions and overview. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[31]  B. Messing,et al.  Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. , 2003, Gastroenterology.

[32]  A. Buchman,et al.  AGA technical review on short bowel syndrome and intestinal transplantation. , 2003, Gastroenterology.

[33]  N. Scott,et al.  Mechanisms of intestinal failure in Crohn's disease , 2001, Diseases of the colon and rectum.

[34]  M. Keighley,et al.  Long-term outcome of surgical management for diffuse jejunoileal Crohn's disease. , 2001, Surgery.

[35]  J. Thompson Inflammatory disease and outcome of short bowel syndrome. , 2000, American journal of surgery.

[36]  J. Nightingale Clinical problems of a short bowel and their treatment , 1994, Proceedings of the Nutrition Society.

[37]  T. O'hanrahan,et al.  Spectrum of intestinal failure in a specialised unit , 1991, The Lancet.